跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retanyst - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retanyst
Approved
STANDARD
Retanyst
S Kant Healthcare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d12d42fd6533cb64
Company
S Kant Healthcare Ltd.
Type
Standard
Approval Details
Approval Id
d12d42fd6533cb64
Drug Approval Philippines Name
Retanyst
Product Name
Retanyst
Registration Number
DRP-15585-02
Brand Name
Retanyst
Generic Name
Nystatin
Dosage Form
Oral Suspension
Dosage Strength
100,000 IU/mL
Manufacturer
S Kant Healthcare Ltd.
Importer
Medinova Pharmaceutical Inc.
Distributor
Reta Drug
Issuance Date
23 September 2024
Expiry Date
06 August 2029
Pharmacologic Category
Antifungal
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d12d42fd6533cb64
Type
Standard
Back to Philippines FDA Approvals